MAP1LC3A and Cirrhosis: In line with the role of TIPRL in the expression of LC3, CD133, and CD44, we demonstrate the significant upregulation of TIPRL and LC3 in tissues of hepatocyte-derived liver diseases while being downregulated in cirrhosis, the terminal stage of fibrosis.